This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Hazelden Foundation Is Proud To Present The Off-Broadway Production Of BILL W. And Dr. BOB By Samuel Shem And Janet Surrey

CENTER CITY, Minn., April 10, 2013 /PRNewswire-USNewswire/ -- The Hazelden Foundation is proud to present the Off-Broadway production of BILL W. and Dr. BOB by Samuel Shem and Janet Surrey. An award-winning play about the astonishing relationship between two men that led to the founding of Alcoholics Anonymous and Al-Anon Family Groups—a great American success story about the power of authentic connection to heal, told with humor and heart. Performances will begin on Monday, July 8, 2013 at the SoHo Playhouse in New York City and opening night is Tuesday, July 16, 2013. 



"The miraculous story, beautifully told, of the men who named the disease and created the cure."—Martin Sheen

BILL W. and Dr. BOB will be directed by Seth Gordon (Associate Artistic Director, Repertory Theatre of St. Louis; Producer/Director Primary Stages, NYC) and will feature the design work of Teresa Snider-Stein (costumes; I'm Not Rappaport) and Ann Wrightson (lighting; August; Osage County , Tony nominee). Roy Gabay Productions is General Manager ( Chaplin, Rock of Ages). Samuel Shem and Janet Surrey are award-winning writers of fiction ( The House of God) and nonfiction ( We Have to Talk: Healing Dialogues Between Women and Men), as well as doctors who have treated alcoholics and addicts for many years at Harvard Medical School.

"On behalf of the Hazelden Foundation, we could not be more thrilled to present this production Off-Broadway at the SoHo Playhouse. It is the perfect venue for BILL W. & Dr. BOB. This production reinforces the Hazelden vision of giving the hope of recovery to all who suffer from addiction, and overcoming the stigma of addiction. Our hope is that everyone whose life has been touched by this disease has an opportunity to experience this play."—Nick Motu, Hazelden publisher & vice president of Marketing and Communications.

1 of 4

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
AAPL $94.19 -1.04%
FB $118.06 0.54%
GOOG $695.70 0.48%
TSLA $222.56 -4.20%
YHOO $36.00 -0.03%


Chart of I:DJI
DOW 17,651.26 -99.65 -0.56%
S&P 500 2,051.12 -12.25 -0.59%
NASDAQ 4,725.6390 -37.5850 -0.79%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs